Vident Investment Advisory’s Recursion Pharmaceuticals RXRX Stock Holding History

Vident Investment Advisory’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$133K	Buy
2023 Q1	$108K	Buy
2022 Q4	$105K	Buy
2022 Q3	$124K	Buy
2022 Q2	$85K	Buy